The quality of laboratory science services can make or break drug development, keeping you on track or derailing your program altogether. A well-planned approach may even accelerate your timelines and make the difference in being first to market. Yet, many drug developers are at a loss when it comes to this critical aspect of their program, unsure how best to proceed. Many factors fuel this uncertainty, as we witness the arrival of new technologies, the rise of new types of therapies and modalities, and the downsizing of biotech and pharma's internal drug development teams. To be certain, there are challenges to overcome. Will the latest trends in laboratory support services offer us solutions?